Ligand Pharm (LGND)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | LGND | AMGN | GILD | CELG | ILMN |
| Company | Ligand Pharm | Amgen Inc | Gilead Sciences Inc | Celgene Corp | Illumina Inc |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NASDAQ | NASDAQ |
| Open | 105.41 | 337.03 | 84.39 | 108.01 | 134.92 |
| High | 106.20 | 338.70 | 84.65 | 108.59 | 136.19 |
| Low | 104.35 | 334.61 | 83.43 | 107.27 | 133.81 |
| Last | 105.01 | 335.95 | 83.90 | 108.24 | 134.39 |
| Change | +1.33 | +3.03 | +0.01 | +0.11 | +3.42 |
| % Change | +1.28% | +0.91% | +0.01% | +0.10% | +2.61% |
| Volume | 86,200 | 1,626,200 | 8,798,200 | 191,230,496 | 1,216,000 |
| 20-Day Average Volume | 92,525 | 1,760,685 | 6,694,930 | 16,188,930 | 1,354,880 |
| Previous Close | 103.68 | 332.92 | 83.89 | 108.13 | 130.97 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | No | Yes |
| Technicals | |||||
| 20-Day Moving Average | 103.89 | 329.59 | 80.07 | 108.17 | 129.20 |
| 20-Day Raw Stochastic | 61.57% | 84.75% | 89.62% | 63.25% | 88.52% |
| 20-Day Relative Strength | 55.77% | 57.67% | 71.87% | 64.69% | 60.50% |
| Weighted Alpha | +81.07 | +27.09 | +18.24 | +46.30 | +8.47 |
| Today's Opinion | 100% Buy | 96% Buy | 88% Buy | 100% Buy | 72% Buy |
| Previous Opinion | 88% Buy | 88% Buy | 88% Buy | 100% Buy | 64% Buy |
| Last Month's Opinion | 100% Buy | 88% Buy | 56% Buy | 100% Buy | 40% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +2.85% since 09/12/24 | +1.78% since 09/12/24 | +0.89% since 09/12/24 | -1.97% since 11/13/19 | +6.45% since 09/12/24 |
| Low | 102.62 on 09/13/24 | 327.15 on 09/13/24 | 81.57 on 09/13/24 | 107.27 on 11/20/19 | 126.31 on 09/13/24 |
| High | 106.65 on 09/16/24 | 339.00 on 09/18/24 | 84.65 on 09/19/24 | 110.53 on 11/14/19 | 136.19 on 09/19/24 |
| 1-Month | |||||
| %Chg | +1.37% since 08/19/24 | +2.43% since 08/19/24 | +12.69% since 08/19/24 | +5.14% since 10/18/19 | -1.11% since 08/19/24 |
| Low | 98.89 on 09/04/24 | 319.00 on 09/06/24 | 74.34 on 08/20/24 | 102.40 on 10/21/19 | 120.51 on 09/12/24 |
| High | 108.83 on 08/29/24 | 339.00 on 09/18/24 | 84.89 on 09/12/24 | 110.70 on 11/13/19 | 137.18 on 08/20/24 |
| 3-Month | |||||
| %Chg | +30.38% since 06/18/24 | +9.79% since 06/18/24 | +32.86% since 06/18/24 | +13.63% since 08/20/19 | +24.32% since 06/18/24 |
| Low | 77.53 on 06/26/24 | 303.55 on 06/20/24 | 64.86 on 06/20/24 | 93.41 on 08/23/19 | 103.52 on 06/28/24 |
| High | 112.13 on 07/31/24 | 346.85 on 07/25/24 | 84.89 on 09/12/24 | 110.70 on 11/13/19 | 137.18 on 08/20/24 |
| 6-Month | |||||
| %Chg | +45.42% since 03/19/24 | +23.63% since 03/19/24 | +14.29% since 03/19/24 | +14.14% since 05/20/19 | +0.92% since 03/19/24 |
| Low | 67.72 on 04/22/24 | 260.68 on 04/19/24 | 62.07 on 05/31/24 | 89.08 on 07/23/19 | 100.08 on 05/30/24 |
| High | 112.13 on 07/31/24 | 346.85 on 07/25/24 | 84.89 on 09/12/24 | 110.70 on 11/13/19 | 144.19 on 03/21/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 1,866,240 | 178,589,936 | 104,514,608 | 77,035,920 | 20,863,522 |
| Shares Outstanding, K | 18,000 | 536,435 | 1,245,853 | 711,714 | 159,300 |
| Annual Sales | 131,310,000 | 28,190,000,000 | 27,116,000,000 | 15,281,000,000 | 4,504,000,000 |
| Annual Net Income | 52,150,000 | 6,717,000,000 | 5,665,000,000 | 4,046,000,000 | -1,161,000,000 |
| Last Quarter Sales | 41,530,000 | 8,388,000,000 | 6,954,000,000 | 4,520,000,000 | 1,112,000,000 |
| Last Quarter Net Income | -51,910,000 | 746,000,000 | 1,614,000,000 | 1,691,000,000 | -1,988,000,000 |
| 60-Month Beta | 1.01 | 0.61 | 0.18 | 1.41 | 1.15 |
| Per-Share Information | |||||
| Most Recent Earnings | 1.40 on 08/06/24 | 4.97 on 08/06/24 | 2.01 on 08/08/24 | 2.99 on 10/31/19 | 0.36 on 08/06/24 |
| Latest Earnings Date | 11/13/24 | 10/29/24 | 11/05/24 | 10/31/19 | 08/06/24 |
| Most Recent Dividend | 2.500 on 04/03/07 | 2.250 on 08/16/24 | 0.770 on 09/13/24 | N/A | N/A |
| Next Ex-Dividends Date | N/A | 08/16/24 | 09/13/24 | N/A | N/A |
| Ratios | |||||
| Price/Earnings ttm | 32.38 | 17.89 | 17.67 | 10.99 | 141.53 |